 | • レポートコード：20QY06-08083 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、脳炎ワクチンのグローバル市場について種類別（中山、北京、P-3、SA 14-14-2）、用途別（子供、大人）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・脳炎ワクチン市場の概要 ・世界の主要地域別脳炎ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の脳炎ワクチン市場規模2015-2026：種類別（中山、北京、P-3、SA 14-14-2） ・世界の脳炎ワクチン市場規模2015-2026：用途別（子供、大人） ・脳炎ワクチンの北米市場規模2015-2020 ・脳炎ワクチンのヨーロッパ市場規模2015-2020 ・脳炎ワクチンの中国市場規模2015-2020 ・脳炎ワクチンの日本市場規模2015-2020 ・脳炎ワクチンの東南アジア市場規模2015-2020 ・脳炎ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Liaoning Chengda、Wuhan Institute of Biological、Valneva、Tiantan Biological Products、Sanofi Pasteur、Chengdu Institute of Biological Products、GlaxoSmithKline、Lanzhou Institute of Biological Products、Zhejiang Tianyuan Bio-Pharmaceutical、Biken） ・脳炎ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・脳炎ワクチンの市場動向・機会・課題 ・調査の結論 |
Encephalitis virus is a mosquito-borne Flavivirus and is transmitted via an enzootic cycle from mosquitoes to amplifying vertebrate hosts such as pigs and wading birds.
It can easily be prevented using vaccines. It is the most common cause of encephalitis in Asia-Pacific. Encephalitis virus can easily be transmitted to humans through an infected mosquito bite and occurs primarily in rural agricultural areas.
Market Analysis and Insights: Global Encephalitis Vaccine Market
The global Encephalitis Vaccine market was valued at US$ 1152.9 million in 2019 and will reach US$ 1695.5 million by the end of 2026, growing at a CAGR of 5.6% during 2020-2026.
Global Encephalitis Vaccine Scope and Market Size
The global Encephalitis Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Encephalitis Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Encephalitis Vaccine market is segmented into
Nakayama
Beijing
P-3
SA 14-14-2
Segment by Application, the Encephalitis Vaccine market is segmented into
Child
Adult
The Encephalitis Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Encephalitis Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Encephalitis Vaccine Market Share Analysis
Encephalitis Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Encephalitis Vaccine business, the date to enter into the Encephalitis Vaccine market, Encephalitis Vaccine product introduction, recent developments, etc.
The major vendors covered:
Liaoning Chengda
Wuhan Institute of Biological
Valneva
Tiantan Biological Products
Sanofi Pasteur
Chengdu Institute of Biological Products
GlaxoSmithKline
Lanzhou Institute of Biological Products
Zhejiang Tianyuan Bio-Pharmaceutical
Biken
Table of Contents
1 Encephalitis Vaccine Market Overview
1.1 Encephalitis Vaccine Product Scope
1.2 Encephalitis Vaccine Segment by Type
1.2.1 Global Encephalitis Vaccine Sales by Type (2020-2026)
1.2.2 Nakayama
1.2.3 Beijing
1.2.4 P-3
1.2.5 SA 14-14-2
1.3 Encephalitis Vaccine Segment by Application
1.3.1 Global Encephalitis Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Child
1.3.3 Adult
1.4 Encephalitis Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Encephalitis Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Encephalitis Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Encephalitis Vaccine Price Trends (2015-2026)
2 Encephalitis Vaccine Estimate and Forecast by Region
2.1 Global Encephalitis Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Encephalitis Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Encephalitis Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Encephalitis Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Encephalitis Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Encephalitis Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Encephalitis Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Encephalitis Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Encephalitis Vaccine Estimates and Projections (2015-2026)
2.4.3 China Encephalitis Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Encephalitis Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Encephalitis Vaccine Estimates and Projections (2015-2026)
2.4.6 India Encephalitis Vaccine Estimates and Projections (2015-2026)
3 Global Encephalitis Vaccine Competition Landscape by Players
3.1 Global Top Encephalitis Vaccine Players by Sales (2015-2020)
3.2 Global Top Encephalitis Vaccine Players by Revenue (2015-2020)
3.3 Global Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Encephalitis Vaccine as of 2019)
3.4 Global Encephalitis Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Encephalitis Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Encephalitis Vaccine Players (Opinion Leaders)
4 Global Encephalitis Vaccine Market Size by Type
4.1 Global Encephalitis Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Encephalitis Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Encephalitis Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Encephalitis Vaccine Price by Type (2014-2020)
4.2 Global Encephalitis Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Encephalitis Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Encephalitis Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Encephalitis Vaccine Price Forecast by Type (2021-2026)
5 Global Encephalitis Vaccine Market Size by Application
5.1 Global Encephalitis Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Encephalitis Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Encephalitis Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Encephalitis Vaccine Price by Application (2015-2020)
5.2 Global Encephalitis Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Encephalitis Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Encephalitis Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Encephalitis Vaccine Price Forecast by Application (2021-2026)
3 North America Encephalitis Vaccine Market Facts & Figures
3.2 North America Encephalitis Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Encephalitis Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Encephalitis Vaccine Sales Market Share by Application (2015-2020)
4 Europe Encephalitis Vaccine Market Facts & Figures
4.2 Europe Encephalitis Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Encephalitis Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Encephalitis Vaccine Sales Market Share by Application (2015-2020)
5 China Encephalitis Vaccine Market Facts & Figures
5.2 China Encephalitis Vaccine Sales Market Share by Company (2015-2020)
5.3 China Encephalitis Vaccine Sales Market Share by Type (2015-2020)
5.4 China Encephalitis Vaccine Sales Market Share by Application (2015-2020)
6 Japan Encephalitis Vaccine Market Facts & Figures
6.2 Japan Encephalitis Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Encephalitis Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Encephalitis Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Encephalitis Vaccine Market Facts & Figures
7.2 Southeast Asia Encephalitis Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Encephalitis Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Encephalitis Vaccine Sales Market Share by Application (2015-2020)
8 India Encephalitis Vaccine Market Facts & Figures
8.2 India Encephalitis Vaccine Sales Market Share by Company (2015-2020)
8.3 India Encephalitis Vaccine Sales Market Share by Type (2015-2020)
8.4 India Encephalitis Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Encephalitis Vaccine Business
12.1 Liaoning Chengda
12.1.1 Liaoning Chengda Encephalitis Vaccine Corporation Information
12.1.2 Liaoning Chengda Encephalitis Vaccine Business Overview and Total Revenue
12.1.3 Liaoning Chengda Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Liaoning Chengda Encephalitis Vaccine Products Offered
12.1.5 Liaoning Chengda Recent Development
12.2 Wuhan Institute of Biological
12.2.1 Wuhan Institute of Biological Encephalitis Vaccine Corporation Information
12.2.2 Wuhan Institute of Biological Encephalitis Vaccine Business Overview and Total Revenue
12.2.3 Wuhan Institute of Biological Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Wuhan Institute of Biological Encephalitis Vaccine Products Offered
12.2.5 Wuhan Institute of Biological Recent Development
12.3 Valneva
12.3.1 Valneva Encephalitis Vaccine Corporation Information
12.3.2 Valneva Encephalitis Vaccine Business Overview and Total Revenue
12.3.3 Valneva Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Valneva Encephalitis Vaccine Products Offered
12.3.5 Valneva Recent Development
12.4 Tiantan Biological Products
12.4.1 Tiantan Biological Products Encephalitis Vaccine Corporation Information
12.4.2 Tiantan Biological Products Encephalitis Vaccine Business Overview and Total Revenue
12.4.3 Tiantan Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Tiantan Biological Products Encephalitis Vaccine Products Offered
12.4.5 Tiantan Biological Products Recent Development
12.5 Sanofi Pasteur
12.5.1 Sanofi Pasteur Encephalitis Vaccine Corporation Information
12.5.2 Sanofi Pasteur Encephalitis Vaccine Business Overview and Total Revenue
12.5.3 Sanofi Pasteur Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Pasteur Encephalitis Vaccine Products Offered
12.5.5 Sanofi Pasteur Recent Development
12.6 Chengdu Institute of Biological Products
12.6.1 Chengdu Institute of Biological Products Encephalitis Vaccine Corporation Information
12.6.2 Chengdu Institute of Biological Products Encephalitis Vaccine Business Overview and Total Revenue
12.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Chengdu Institute of Biological Products Encephalitis Vaccine Products Offered
12.6.5 Chengdu Institute of Biological Products Recent Development
12.7 GlaxoSmithKline
12.7.1 GlaxoSmithKline Encephalitis Vaccine Corporation Information
12.7.2 GlaxoSmithKline Encephalitis Vaccine Business Overview and Total Revenue
12.7.3 GlaxoSmithKline Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 GlaxoSmithKline Encephalitis Vaccine Products Offered
12.7.5 GlaxoSmithKline Recent Development
12.8 Lanzhou Institute of Biological Products
12.8.1 Lanzhou Institute of Biological Products Encephalitis Vaccine Corporation Information
12.8.2 Lanzhou Institute of Biological Products Encephalitis Vaccine Business Overview and Total Revenue
12.8.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Lanzhou Institute of Biological Products Encephalitis Vaccine Products Offered
12.8.5 Lanzhou Institute of Biological Products Recent Development
12.9 Zhejiang Tianyuan Bio-Pharmaceutical
12.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Corporation Information
12.9.2 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Business Overview and Total Revenue
12.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Products Offered
12.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
12.10 Biken
12.10.1 Biken Encephalitis Vaccine Corporation Information
12.10.2 Biken Encephalitis Vaccine Business Overview and Total Revenue
12.10.3 Biken Encephalitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Biken Encephalitis Vaccine Products Offered
12.10.5 Biken Recent Development
13 Encephalitis Vaccine Manufacturing Cost Analysis
13.1 Encephalitis Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Encephalitis Vaccine
13.4 Encephalitis Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Encephalitis Vaccine Distributors List
14.3 Encephalitis Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Encephalitis Vaccine Sales (M Doses) Growth Rate by Type (2020-2026)
Table 2. Global Encephalitis Vaccine Sales (M Doses) Comparison by Application (2020-2026)
Table 3. Global Market Encephalitis Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Encephalitis Vaccine Sales (M Doses) by Region (2015-2020)
Table 5. Global Encephalitis Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Encephalitis Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Encephalitis Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Encephalitis Vaccine Sales (M Doses) Forecast by Region (2021-2026)
Table 9. Global Encephalitis Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Encephalitis Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Encephalitis Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Encephalitis Vaccine (M Doses) of Key Companies (2015-2020)
Table 13. Global Encephalitis Vaccine Sales Share by Company (2015-2020)
Table 14. Global Encephalitis Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Encephalitis Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Encephalitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Encephalitis Vaccine as of 2019)
Table 17. Global Encephalitis Vaccine Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Encephalitis Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Encephalitis Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Encephalitis Vaccine Players
Table 22. Global Encephalitis Vaccine Sales (M Doses) by Type (2015-2020)
Table 23. Global Encephalitis Vaccine Sales Share by Type (2015-2020)
Table 24. Global Encephalitis Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Encephalitis Vaccine Price (M Doses) by Type (2015-2020)
Table 26. Global Encephalitis Vaccine Sales Share by Type (2021-2026)
Table 27. Global Encephalitis Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Encephalitis Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Encephalitis Vaccine Price (M Doses) by Type (2021-2026)
Table 30. Global Encephalitis Vaccine Sales (M Doses) by Application (2015-2020)
Table 31. Global Encephalitis Vaccine Sales Share by Application (2015-2020)
Table 32. Global Encephalitis Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Encephalitis Vaccine Price (M Doses) by Application (2015-2020)
Table 34. Global Encephalitis Vaccine Sales (M Doses) by Application (2021-2026)
Table 35. Global Encephalitis Vaccine Sales Share by Application (2021-2026)
Table 36. Global Encephalitis Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Encephalitis Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Encephalitis Vaccine Price (M Doses) by Application (2021-2026)
Table 39. United States Encephalitis Vaccine Sales (M Doses) by Company (2015-2020)
Table 40. United States Encephalitis Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Encephalitis Vaccine Sales (M Doses) by Type (2015-2020)
Table 42. United States Encephalitis Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Encephalitis Vaccine Sales (M Doses) by Application (2015-2020)
Table 44. United States Encephalitis Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Encephalitis Vaccine Sales (M Doses) by Company (2015-2020)
Table 46. Europe Encephalitis Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Encephalitis Vaccine Sales (M Doses) by Type (2015-2020)
Table 48. Europe Encephalitis Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Encephalitis Vaccine Sales (M Doses) by Application (2015-2020)
Table 50. Europe Encephalitis Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Encephalitis Vaccine Sales (M Doses) by Company (2015-2020)
Table 52. China Encephalitis Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Encephalitis Vaccine Sales (M Doses) by Type (2015-2020)
Table 54. China Encephalitis Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Encephalitis Vaccine Sales (M Doses) by Application (2015-2020)
Table 56. China Encephalitis Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Encephalitis Vaccine Sales (M Doses) by Company (2015-2020)
Table 58. Japan Encephalitis Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Encephalitis Vaccine Sales (M Doses) by Type (2015-2020)
Table 60. Japan Encephalitis Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Encephalitis Vaccine Sales (M Doses) by Application (2015-2020)
Table 62. Japan Encephalitis Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Encephalitis Vaccine Sales (M Doses) by Company (2015-2020)
Table 64. Southeast Asia Encephalitis Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Encephalitis Vaccine Sales (M Doses) by Type (2015-2020)
Table 66. Southeast Asia Encephalitis Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Encephalitis Vaccine Sales (M Doses) by Type (2015-2020)
Table 68. Southeast Asia Encephalitis Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Encephalitis Vaccine Sales (M Doses) by Company (2015-2020)
Table 70. India Encephalitis Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Encephalitis Vaccine Sales (M Doses) by Type (2015-2020)
Table 72. India Encephalitis Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Encephalitis Vaccine Sales (M Doses) by Application (2015-2020)
Table 74. India Encephalitis Vaccine Sales Market Share by Application (2015-2020)
Table 75. Liaoning Chengda Corporation Information
Table 76. Liaoning Chengda Description and Business Overview
Table 77. Liaoning Chengda Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Liaoning Chengda Encephalitis Vaccine Product
Table 79. Liaoning Chengda Recent Development
Table 80. Wuhan Institute of Biological Corporation Information
Table 81. Wuhan Institute of Biological Description and Business Overview
Table 82. Wuhan Institute of Biological Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Wuhan Institute of Biological Encephalitis Vaccine Product
Table 84. Wuhan Institute of Biological Recent Development
Table 85. Valneva Corporation Information
Table 86. Valneva Description and Business Overview
Table 87. Valneva Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Valneva Encephalitis Vaccine Product
Table 89. Valneva Recent Development
Table 90. Tiantan Biological Products Corporation Information
Table 91. Tiantan Biological Products Description and Business Overview
Table 92. Tiantan Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Tiantan Biological Products Encephalitis Vaccine Product
Table 94. Tiantan Biological Products Recent Development
Table 95. Sanofi Pasteur Corporation Information
Table 96. Sanofi Pasteur Description and Business Overview
Table 97. Sanofi Pasteur Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Sanofi Pasteur Encephalitis Vaccine Product
Table 99. Sanofi Pasteur Recent Development
Table 100. Chengdu Institute of Biological Products Corporation Information
Table 101. Chengdu Institute of Biological Products Description and Business Overview
Table 102. Chengdu Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Chengdu Institute of Biological Products Encephalitis Vaccine Product
Table 104. Chengdu Institute of Biological Products Recent Development
Table 105. GlaxoSmithKline Corporation Information
Table 106. GlaxoSmithKline Description and Business Overview
Table 107. GlaxoSmithKline Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. GlaxoSmithKline Encephalitis Vaccine Product
Table 109. GlaxoSmithKline Recent Development
Table 110. Lanzhou Institute of Biological Products Corporation Information
Table 111. Lanzhou Institute of Biological Products Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Lanzhou Institute of Biological Products Description and Business Overview
Table 113. Lanzhou Institute of Biological Products Encephalitis Vaccine Product
Table 114. Lanzhou Institute of Biological Products Recent Development
Table 115. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information
Table 116. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Zhejiang Tianyuan Bio-Pharmaceutical Description and Business Overview
Table 118. Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Product
Table 119. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development
Table 120. Biken Corporation Information
Table 121. Biken Description and Business Overview
Table 122. Biken Encephalitis Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Biken Encephalitis Vaccine Product
Table 124. Biken Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Encephalitis Vaccine Distributors List
Table 128. Encephalitis Vaccine Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Encephalitis Vaccine Product Picture
Figure 2. Global Encephalitis Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Encephalitis Vaccine Market Share by Application in 2020 & 2026
Figure 6. Child Examples
Figure 7. Adult Examples
Figure 8. Global Encephalitis Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 9. Global Encephalitis Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Encephalitis Vaccine Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Encephalitis Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Encephalitis Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Encephalitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Encephalitis Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 15. Europe Encephalitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Encephalitis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Encephalitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Encephalitis Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Encephalitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Encephalitis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Encephalitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Encephalitis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Encephalitis Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Encephalitis Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Encephalitis Vaccine Players Market Share by Revenue in Encephalitis Vaccine 2015 & 2019
Figure 26. Encephalitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Encephalitis Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Encephalitis Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Encephalitis Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Encephalitis Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Encephalitis Vaccine Sales Market Share by Type in 2019
Figure 32. United States Encephalitis Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Encephalitis Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Encephalitis Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Encephalitis Vaccine Sales Market Share by Application in 2019
Figure 36. China Encephalitis Vaccine Sales Market Share by Company in 2019
Figure 37. China Encephalitis Vaccine Sales Market Share by Type in 2019
Figure 38. China Encephalitis Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Encephalitis Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Encephalitis Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Encephalitis Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Encephalitis Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Encephalitis Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Encephalitis Vaccine Sales Market Share by Application in 2019
Figure 45. India Encephalitis Vaccine Sales Market Share by Company in 2019
Figure 46. India Encephalitis Vaccine Sales Market Share by Type in 2019
Figure 47. India Encephalitis Vaccine Sales Market Share by Application in 2019
Figure 48. Liaoning Chengda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Wuhan Institute of Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Valneva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Tiantan Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Chengdu Institute of Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Lanzhou Institute of Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Zhejiang Tianyuan Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Biken Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Encephalitis Vaccine
Figure 60. Manufacturing Process Analysis of Encephalitis Vaccine
Figure 61. Encephalitis Vaccine Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
日本脳炎（JE）ワクチンの世界市場レポート2020 Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. How long this protection lasts is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.…- 脳炎ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Encephalitis Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.4% in the forecast period of 2020 to 2025 and will expected to reach USD 1461.8 million by 2025, from USD 1186.3 million in 2019. The Encephalitis Va…
- 日本脳炎ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Japanese Encephalitis (JE) Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Japanese E…
- 多価肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis. Market Analysis and Insights: Global Pneumococcal Vaccine Polyvalent Market The global Pneumococcal Vaccine Polyvalent market was valued at US$ xx …
- 肺炎球菌ワクチンの世界市場レポート2020 Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40% in 2015. The second place is Europe, following North America with sales market share over 18…